Specifics of allelic polymorphism of genes associated with increased therombogenesis in pregnant women with fetal loss syndrome


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The Up-to-date research of perinatal mortality in Russia has shown change in its structure with increase of proportion of antenatal mortality in the first place, which may be declarative of disorders in fetal vital activities. Reproductive losses in different periods of pregnancy are increasingly frequently united under the term of fetal loss syndrome (FLS), regardless of ethiopathogenic factors. The mostly discussed issue is thrombotic disorders related to inherited and aquired thrombophilia. Research objective was to evaluate the role of adverse allelic variant genes carriage, associated with increased thrombogenesis, in development of FLS. 105 pregnant women with FLS or FLS risk factors in the past have been examined. The women have been affiliated with SPb GBUZ «Women's clininc N 22». The women have been tested for gene mutations in Factor V (FV Leiden), prothrombin, β-subunit of factor I, plasminogen activator inhibitor-I, methylenete-trahydrofolate reductase and glucoprotein IIIa. The study results have shown that 100 per cents of women in the study group with FLS or FLS risk factors in the past have been carriers of at least one allelic variant associated with increased risk of thrombogenesis. A combination of two or more adverse geetic variants (potential risk factors for FLS) have been registered in the overwhelming majority of cases. The incidence of Leiden and genotype 1565CC gene GpIIIa mutations in both study groups was significantly different as compared to the population. The study results demonstrate the necessity to determine adverse allelic variants of the known genes along with the classical deteminants of inherited thrombophilia in everyday obstetrical practice, as it allows to sportlight individual mechnisms of development of FLS and the most commonly seen complications of pregnancy.

全文:

受限制的访问

作者简介

Alla Nikolaeva

Saint Petersburg State Pediatric Medical University

Email: alla-nikolaeva2007@yandex.ru
MD, PhD, Research Assistant, Department of Pediatric Gynecology and women´s reproductology FP and DPO

Sergey Kapustin

FGBU “The Russian Scientific Reseach Institute of hematology and transfusiology” of FMBA of Russia

Email: kapustin.sergey@mail.ru
Doctor of Biological Sciencies, Chief of Biochemistry Lab

Lyudmila Papayan

FGBU “The Russian Scientific Reseach Institute of hematology and transfusiology” of FMBA of Russia

Email: papayan@mail.ru
MD, PhD, Chief of Lab. of Blood Coagulation

Flora Kutueva

Saint Petersburg State Pediatric Medical University

Email: Flora-kutueva@mail.ru
MD, PhD, Research Assistant, Department of Pediatric Gynecology and women´s reproductology FP and DPO

参考

  1. Бицадзе В. О., Макацария А. Д., Хизроева Д. Х. Тромбофилия как важнейшее звено патогенеза осложнений беременности. Практическая мед. 2012; 60: 22-9.
  2. Капустин С. И., Шмелева В. М., Сидорова Ж. Ю. Молекулярные детерминанты наследственной тромбофилии: современное состояние и перспективы генодиагностики. Вестник гематологии. 2010; VII (4): 84-92.
  3. Николаева А. Е., Кутуева Ф. Р., Папаян Л. П. Наследственная тромбофилия (фактор V Лейден) и привычное невынашивание беременности (случай из практики). Тромбоз, гемостаз и реология. 2010; 2 (42): 72-76.
  4. Agorastos T., Karavida А., Lambropoulos A., Matern J. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome: Fetal Neonatal Med. 2002; 12(4): 267-73.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Nikolaeva A.E., Kapustin S.I., Papayan L.P., Kutueva F.R., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


##common.cookie##